Advocacy intelligence hub — real-time data for patient organizations
Phathom Pharmaceuticals, Inc. — PHASE2
University of Michigan — NA
Sanofi
University of North Carolina, Chapel Hill — PHASE4
Universitaire Ziekenhuizen KU Leuven — NA
Oslo University Hospital
East and North Hertfordshire NHS Trust — NA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — NA
Eupraxia Pharmaceuticals Inc. — PHASE1, PHASE2
Children's Hospital Medical Center, Cincinnati
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Primary eosinophilic gastrointestinal disease news →
William E Shomali, MD, M.D
Stanford Cancer Institute Palo Alto
📍 STANFORD, CA
Paul Martin
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Emma Scott
SWOG Cancer Research Network
Marcelo Serra, PhD
HIBA
📍 Buenos Aires, Buenos Aires
Soledad Kleppe, MD
HIBA
Ramesh Ramanathan
University of Pittsburgh
📍 PITTSBURGH, PA
View all Primary eosinophilic gastrointestinal disease specialists →